article · Informatics in Medicine Unlocked
Antibiotic resistance is a growing concern in healthcare and medicine. This research was carried out to analyze whole genome sequences of Klebsiella pneumoniae ST16 with the goal of identifying genes that cause resistance to antibiotics and find potential substances that can inhibit their growth. The study discovered genes that contribute to resistance against types of antibiotics such as macrolides, fluoroquinolones, aminoglycosides, sulphonamides, rifampicin, trimethoprim, and beta-lactams. Notable genes identified include blaTEM 1B, blaCTX M 15, and blaNDM-1. Furthermore, changes were observed in the acrR, ompK36, and gyrA genes, along with alterations in the corresponding acids, which are associated with resistance. The analysis also examined the alleles at each locus and found that the FIA locus had a new allele. Molecular docking results revealed that baicalein showed docking scores of −7.7 kcal/mol when binding with New Delhi Metallo 1 (NDM-1) related to beta-lactams. The RMSD plot demonstrated behavior for both Baicalein and Adapalene complexes of NDM-1 over a 50 ns simulation period. However, the higher Rg value for the drug-protein complex (NDM-1 Beta-Lactamase 1-Adapalene) indicates it may be slightly unstable in interaction compared to our test compound-protein complex (NDM-1 Beta-Lactamase 1-Baicalein). Summarily, the study offers information about how antibiotic resistance works against the NDM-1 gene and its role in beta-lactam resistance based on analysis which reveals that beyond baicalein, other excellent bioactive (taxifolin, and ellagic acid) strongly bind to the NDM 1 domain and can be further investigated experimentally.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.imu.2023.101441
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.